1 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件: 46 46 💬 |
2 | Belimumab plus Early Vaccination | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
3 | Belimumab plus Late Vaccination | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
4 | COVID-19 vaccination | - | - | - | - | 1件: 13 13 💬 |
5 | Human papillomavirus vaccination (Gardasil) | 4件: Human papillomavirus type 11 L1 capsid protein antigen Human papillomavirus type 11 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 💬 |
6 | Influenza vaccination | - | - | - | - | 1件: 299 299 💬 |
7 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件: 107 107 💬 |
8 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | 1件: Myelin basic protein Myelin basic protein | - | - | - | 1件: 13 13 💬 |
9 | Prevenar vaccination | - | - | - | - | 1件: 46 46 💬 |
10 | T cell vaccination | - | - | - | - | 1件: 13 13 💬 |
11 | T-Cell Vaccination | - | - | - | - | 1件: 13 13 💬 |
12 | Vaccination | - | - | - | - | 1件: 49 49 💬 |
13 | Vaccination against TBE | - | - | - | - | 1件: 46 46 💬 |
14 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 💬 |